(Q33201845)

23 July 2017

A self-processing ribozyme cassette: utility against human papillomavirus 11 E6/E7 mRNA and hepatitis B virus (English)

1 reference

23 July 2017

0 references

1 reference

1 reference

3

John D Morrey

1 reference

23 July 2017

Wei-Hua Pan

1

1 reference

PubMed ID

15093190

23 July 2017

Ping Xin

series ordinal

2

1 reference

PubMed ID

15093190

23 July 2017

Gary A Clawson

series ordinal

4

1 reference

23 July 2017

1 April 2004

1 reference

23 July 2017

1 reference

23 July 2017

9

1 reference

23 July 2017

4

1 reference

23 July 2017

596-606

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

23 July 2017

1 reference

Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Construction of a directed hammerhead ribozyme library: towards the identification of optimal target sites for antisense-mediated gene inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Cleavage of highly structured viral RNA molecules by combinatorial libraries of hairpin ribozymes. The most effective ribozymes are not predicted by substrate selection rules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

A selection system for identifying accessible sites in target RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Rapid identification of efficient target cleavage sites using a hammerhead ribozyme library in an iterative manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Nucleotide sequences in Xenopus 5S DNA required for transcription termination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Survey and summary: transcription by RNA polymerases I and III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Relationships between the activities in vitro and in vivo of various kinds of ribozyme and their intracellular localization in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Triple ribozyme-mediated down-regulation of the retinoblastoma gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Growth inhibition by a triple ribozyme targeted to repetitive B2 transcripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Involvement of the fungal nuclear migration gene nudC human homolog in cell proliferation and mitotic spindle formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

The poly(A) tail inhibits the assembly of a 3'-to-5' exonuclease in an in vitro RNA stability system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Identification of genes that function in the TNF-alpha-mediated apoptotic pathway using randomized hybrid ribozyme libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

RNA-protein hybrid ribozymes that efficiently cleave any mRNA independently of the structure of the target RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Using reliability information to annotate RNA secondary structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Kinetic selection of HPV 16 E6/E7-directed antisense nucleic acids: anti-proliferative effects on HPV 16-transformed cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

A novel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfection of undesired DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Improved DNA: liposome complexes for increased systemic delivery and gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Ribozyme gene therapy: applications for molecular medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Molecular therapeutics of HBV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Molecular therapies for viral hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Gene therapy approaches to HIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Chimeric DNA-RNA hammerhead ribozyme targeting PDGF A-chain mRNA specifically inhibits neointima formation in rat carotid artery after balloon injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Therapies directed at vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Repression of hepatitis B virus X gene expression by hammerhead ribozymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Efficient hammerhead ribozyme-mediated cleavage of the structured hepatitis B virus encapsidation signal in vitro and in cell extracts, but not in intact cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Expression and functional characteristics of calpain 3 isoforms generated through tissue-specific transcriptional and posttranscriptional events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

High-level hepatitis B virus replication in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Adenovirus-mediated expression of a ribozyme to c-myb mRNA inhibits smooth muscle cell proliferation and neointima formation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2003.12.013

1 reference

23 July 2017

1 reference

PubMed ID

15093190